136 related articles for article (PubMed ID: 6932997)
1. Second malignancy in patients treated by Hodgkin's disease.
Baccarani M; Bosi A; Papa G
Cancer; 1980 Oct; 46(8):1735-40. PubMed ID: 6932997
[TBL] [Abstract][Full Text] [Related]
2. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital.
Cellai E; Magrini SM; Masala G; Alterini R; Costantini AS; Rigacci L; Olmastroni L; Papi MG; Spediacci MA; Innocenti F; Bellesi G; Ferrini PR; Biti G
Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1327-37. PubMed ID: 11286841
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
Rosner F; Grünwald H
Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
[TBL] [Abstract][Full Text] [Related]
4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini PL; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
[TBL] [Abstract][Full Text] [Related]
6. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
Coltman CA; Dixon DO
Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
[TBL] [Abstract][Full Text] [Related]
8. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
9. Acute leukaemia in patients treated for Hodgkin's disease.
Papa G; Mauro FR; Anselmo AP; Cimino G; Alimena G; Amadori S; D'Arcangelo E; Giannarelli D; Bosi A; Bellesi G
Br J Haematol; 1984 Sep; 58(1):43-52. PubMed ID: 6466571
[TBL] [Abstract][Full Text] [Related]
10. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
11. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
12. Second malignancy complicating Hodgkin's disease.
Tawil E; Mercier JP
J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease terminating in a T-cell immunoblastic leukemia.
Dick FR; Maca RD; Hankenson R
Cancer; 1978 Sep; 42(3):1325-9. PubMed ID: 308839
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases.
Brenner B; Carter A; Sharon R; Tatarsky I
Oncology; 1984; 41(2):83-7. PubMed ID: 6584810
[TBL] [Abstract][Full Text] [Related]
15. [Development of second tumors in patients with Hodgkin's disease (review of the literature and personal data)].
Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP
Vopr Onkol; 1987; 33(5):11-8. PubMed ID: 3590664
[TBL] [Abstract][Full Text] [Related]
16. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
[TBL] [Abstract][Full Text] [Related]
17. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
18. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
Cadman EC; Capizzi RL; Bertino JR
Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies after treatment for Hodgkin's disease.
Várady E; Deák B; Molnár ZS; Rosta A; Schneider T; Esik O; Eckhardt S
Leuk Lymphoma; 2001; 42(6):1275-81. PubMed ID: 11911408
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
